Hirano, Takao
Kumazaki, Akane
Tomihara, Ryuji
Ito, Syun
Hoshiyama, Ken
Murata, Toshinori
Article History
Received: 19 May 2023
Accepted: 27 June 2023
First Online: 5 July 2023
Competing interests
: Takao Hirano reports personal fees from Novartis Pharma K.K., Bayer, Canon, Kowa Pharmaceutical, Senju Pharmaceutical, Chugai Pharmaceutical and Carl Zeiss Meditec. Toshinori Murata reports personal fees from Novartis Pharma K.K., Bayer, Canon, Kowa Pharmaceutical, Senju Pharmaceutical, Chugai Pharmaceutical, Kyowa Kirin and Carl Zeiss Meditec Other authors have no conflicts of interest to disclose.